Comparative Pharmacology
Head-to-head clinical analysis: DELATESTRYL versus DEPO TESTOSTERONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELATESTRYL versus DEPO TESTOSTERONE.
DELATESTRYL vs DEPO-TESTOSTERONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Testosterone ester; binds to androgen receptors, activating gene transcription and promoting protein synthesis, muscle growth, and secondary sexual characteristics.
Testosterone binds to androgen receptors, activating gene transcription that promotes development of male secondary sexual characteristics, anabolic effects, and erythropoiesis.
50 to 200 mg intramuscularly every 2 to 4 weeks.
50-400 mg IM every 2-4 weeks
None Documented
None Documented
8 days (terminal); requires 5-6 weeks to reach steady state with weekly dosing
The terminal elimination half-life of testosterone cypionate after intramuscular injection is approximately 8 days, allowing for dosing every 2-4 weeks.
Urinary (90% as glucuronide and sulfate conjugates, 5% as unchanged drug); fecal (5%)
Testosterone is primarily excreted in urine as glucuronide and sulfate conjugates (90%) and in feces via bile (10%).
Category C
Category D/X
Androgen
Androgen